SCHEMBL7795568

SCHEMBL7795568

CC(Nc1[c]cccc1)N1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 7/20 0.37
CYP3A4 P08684 6/20 0.37
CYP2D6 P10635 6/20 0.37
CYP2C19 P33261 6/20 0.37
CYP1A2 P05177 5/20 0.37
CYP2C9 P11712 4/20 0.37
KCNH2 Q12809 4/20 0.37
KCNE1 P15382 2/20 0.37
ALDH1A1 P00352 6/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
LMNA P02545 2/20 0.34
ATM Q13315 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
GAA P10253 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 1/20 0.32
ALOX12 P18054 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3118094 0.84 KCNA5 (0.38) KCNA5CYP3A4CYP2C19ALDH1A1KMT2A
SCHEMBL700215 0.77 TDP1 (0.44) CYP3A4ALDH1A1KMT2AMEN1LMNA
SCHEMBL3757771 0.76 ATM (0.37) CYP2C19CYP1A2ALDH1A1KMT2AMEN1
SCHEMBL27485301 0.75 TDP1 (0.43) CYP3A4ALDH1A1KMT2AMEN1LMNA
SCHEMBL11844280 0.74 TDP1 (0.54) KCNA5CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL8725280 0.72 CYP2D6 (0.44) KCNA5CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL5675159 0.72 TDP1 (0.56) KCNA5CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL8131986 0.72 ALDH1A1 (0.42) CYP2C19CYP1A2ALDH1A1KMT2AMEN1
SCHEMBL9367012 0.71 CYP2D6 (0.41) KCNA5CYP3A4CYP2D6CYP2C19CYP1A2
SCHEMBL4152132 0.70 KDM1A (0.42) KCNA5CYP3A4CYP2D6CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010012899-A1 Oligomeric methine dyes CLARIANT FINANCE ( BVI) LIMITED 2001-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012899-A1 Oligomeric methine dyes INMT, DDT, DDC KCNA5 1802/4885CYP3A4 1133/4885CYP2D6 1866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.